Literature DB >> 25886654

Pharmacological treatment of child and adolescent disruptive behaviour disorders: between the scylla and charybdis, what do the data say?

Thomas C R Wilkes1, Mary Kay Nixon2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25886654      PMCID: PMC4344945          DOI: 10.1177/070674371506000201

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  8 in total

Review 1.  Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management.

Authors:  Nancy Scotto Rosato; Christoph U Correll; Elizabeth Pappadopulos; Alanna Chait; Stephen Crystal; Peter S Jensen
Journal:  Pediatrics       Date:  2012-05-28       Impact factor: 7.124

Review 2.  Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tamara Pringsheim; Darren Lam; Heidi Ching; Scott Patten
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

3.  Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.

Authors:  Marie-Christine Brault; Éric Lacourse
Journal:  Can J Psychiatry       Date:  2012-02       Impact factor: 4.356

4.  The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009.

Authors:  Tamara Pringsheim; Darren Lam; Scott B Patten
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-02       Impact factor: 2.576

Review 5.  The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.

Authors:  Tamara Pringsheim; Lauren Hirsch; David Gardner; Daniel A Gorman
Journal:  Can J Psychiatry       Date:  2015-02       Impact factor: 4.356

Review 6.  The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.

Authors:  Tamara Pringsheim; Lauren Hirsch; David Gardner; Daniel A Gorman
Journal:  Can J Psychiatry       Date:  2015-02       Impact factor: 4.356

7.  Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.

Authors:  Daniel A Gorman; David M Gardner; Andrea L Murphy; Mark Feldman; Stacey A Bélanger; Margaret M Steele; Khrista Boylan; Kate Cochrane-Brink; Roxanne Goldade; Paul R Soper; Judy Ustina; Tamara Pringsheim
Journal:  Can J Psychiatry       Date:  2015-02       Impact factor: 4.356

Review 8.  Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review.

Authors:  Rachel Neuhut; Jean-Pierre Lindenmayer; Raul Silva
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

  8 in total
  1 in total

1.  Choosing Wisely: Wise Choices in Psychiatry.

Authors:  Douglas Urness; Naomi J Parker; Mark J Rapoport; Thomas C R Wilkes
Journal:  Can J Psychiatry       Date:  2016-04-06       Impact factor: 4.356

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.